Author

S. Thai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Cartaya· 2 shared A.-r. Collier· 2 shared D. Barouch· 2 shared E. Borducchi· 2 shared E. M. Bahnson· 2 shared J. Miller· 2 shared K. McMahan· 2 shared M. Rowe· 2 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. Cartaya

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Persistent Activation of Chronic Inflammatory Pathways in Long Covid

M. Aid, K. McMahan, N. Hachmann, J. Miller, E. Borducchi, D. Hope, M. Rowe, E. Schonberg, S. Thai, A.-r. Collier, J. Mullington, D. Barouch

The paper identifies persistent activation of inflammatory pathways in Long Covid patients compared to controls and links acute infection severity to Long Covid development.

bioRxiv · May 11, 2024 · PreprintImmunology

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters

A.-r. Collier, J. Miller, N. Hachmann, K. McMahan, J. Liu, E. Bondzie, L. Gallup, M. Rowe, E. Shonberg, S. Thai, J. Barrett, E. Borducchi, E. Bouffard, C. Jacob-Dolan, C. Mazurek, , D. Barouch

This study compares neutralizing antibody titers after monovalent and bivalent mRNA boosters against SARS-CoV-2, finding comparable levels against BA.5.

bioRxiv · Oct 24, 2022Immunology

Antioxidant Response Activating nanoParticles (ARAPas) localize to atherosclerotic plaque and locally activate the Nrf2 pathway

S. L. Maiocchi, A. Cartaya, S. Thai, A. Akerman, E. M. Bahnson

This study develops ARAPas, nanoparticles that target atherosclerotic plaque and activate the Nrf2 pathway, showing anti-inflammatory effects and increased Nrf2 target gene expression in mouse models.

bioRxiv · Sep 16, 2021Bioengineering

Nrf2 activator-encapsulating polymeric nanoparticles and LDL-like nanoparticles target atherosclerotic plaque

S. L. Maiocchi, S. Thai, A. Cartaya, A. Anwar, I. Corbin, E. M. Bahnson

This study develops and tests two types of nanoparticles that target atherosclerotic plaque to improve delivery of redox-based therapies.

bioRxiv · Jun 10, 2020 · PreprintBioengineering